Retraction Note: Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice

Z Jin; B-X Jia; L-D Tan; Q-M Chen; Y-H Liu

doi:10.26355/eurrev_202210_29864

Retraction Note: Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice

Eur Rev Med Pharmacol Sci. 2022 Oct;26(19):6892. doi: 10.26355/eurrev_202210_29864.

Authors

Z Jin¹, B-X Jia, L-D Tan, Q-M Chen, Y-H Liu

Affiliation

¹ Department of Hepatobiliary and Pancreatic Surgery, the First Hospital of Jilin University, Changchun, Jilin, China.

PMID: 36263565
DOI: 10.26355/eurrev_202210_29864

Abstract

The article "Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice, by Z. Jin, B.-X. Jia, L.-D. Tan, Q.-M. Chen, Y.-H. Liu, published in Eur Rev Med Pharmacol Sci 2020; 24 (23): 12368-12379-DOI: 10.26355/eurrev_202012_24031-PMID: 33336757" has been retracted by the authors as they cannot ensure the reliability of the manuscript due to inaccuracies in the conclusions and in the experiment (the cell migration and invasion assay along with the cell cycle arrest assay are missing). The Publisher apologizes for any inconvenience this may cause https://www.europeanreview.org/article/24031.

Publication types

Retraction of Publication